(+-)-cis-2-methyl-spiro(1,3-oxathiolane-5,3')quinuclidine, an M1 selective cholinergic agonist, attenuates cognitive dysfunctions in an animal model of Alzheimer's disease
FISHER, A, BRANDEIS, R, KARTON, I, PITTEL, Z, GURWITZ, D, HARING, R, SAPIR, M, LEVY, A, HELDAN, E
Published in The Journal of pharmacology and experimental therapeutics (01.04.1991)
Get full text
Published in The Journal of pharmacology and experimental therapeutics (01.04.1991)
Journal Article
(+-)-cis-2-methyl-spiro(1,3-oxathiolane-5,3') quinuclidine (AF102B): a new M1 agonist attenuates cognitive dysfunctions in AF64A-treated rats
Fisher, A, Brandeis, R, Pittel, Z, Karton, I, Sapir, M, Dachir, S, Levy, A, Heldman, E
Published in Neuroscience letters (31.07.1989)
Published in Neuroscience letters (31.07.1989)
Get more information
Journal Article
AF102B: rational treatment strategy for Alzheimer's disease: recent advances
Fisher, A, Brandeis, R, Karton, I, Pittel, Z, Dachir, S, Sapir, M, Grunfeld, Y, Levy, A, Heldman, E
Published in Advances in neurology (1990)
Get more information
Published in Advances in neurology (1990)
Journal Article
모발 섬유 스타일링을 위한 개선된 조성물 및 방법
BLUVSTEIN ALEXANDER, KARTON YISHAI, ABRAMOVICH SAGI, ASHER TAMAR, KOJOKARO NIR
Year of Publication 20.05.2024
Get full text
Year of Publication 20.05.2024
Patent
SPIRO BRIDGED AND UNBRIDGED HETEROCYCLIC COMPOUNDS
KARTON, YISHAI, FISHER, ABRAHAM, SHIRIN, AZRA, MESHULAM, HAIM, SEGALL, YOFFI
Year of Publication 01.10.1999
Get full text
Year of Publication 01.10.1999
Patent